NCT02600208View on ClinicalTrials.gov

Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies with Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Hematologic Malignancies

Interventions

DEVICE

CliniMACs

Depletion of Alpha Beta T cells in the PBSC graft

Trial Locations (1)

53226

Children's Hospital of Wisconsin, Milwaukee

Sponsors

Collaborators (1)

Miltenyi Biotec, Inc.

All Listed Sponsors

collaborator

Miltenyi Biotec, Inc.

INDUSTRY

lead

Julie-An M. Talano

OTHER